Invention Grant
- Patent Title: LSD1 inhibitors and medical uses thereof
-
Application No.: US17241315Application Date: 2021-04-27
-
Publication No.: US11547695B2Publication Date: 2023-01-10
- Inventor: Francois Brucelle , Victor S. Gehling , Avinash Khanna
- Applicant: Constellation Pharmaceuticals, Inc.
- Applicant Address: US MA Boston
- Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee: Constellation Pharmaceuticals, Inc.
- Current Assignee Address: US MA Boston
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Michael J. DeGrazia
- Main IPC: C07D205/12
- IPC: C07D205/12 ; C07D221/20 ; A61K31/397 ; A61P31/22 ; A61P31/18 ; A61P35/02 ; A61K31/438 ; A61P35/00
Abstract:
Provided are novel compounds of Formula (I or Ia′): and pharmaceutically acceptable salts thereof, which are useful for treating a variety of diseases, disorders or conditions, associated with LSD1. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I or Ia′), pharmaceutically acceptable salts thereof, and methods for their use in treating one or more diseases, disorders or conditions, associated with LSD1.
Public/Granted literature
- US20220079917A1 LSD1 INHIBITORS AND MEDICAL USES THEREOF Public/Granted day:2022-03-17
Information query
